Funding Received
$8.9 Million in 2 Rounds from 3 Investors
Most Recent Funding
$2.9 Million Grant on June 17, 2014
Headquarters:
Kent
Description:
Ziarco is a biotechnology company developing therapies for inflammatory and allergic diseases.
Categories:
Biotechnology
Website:
http://www.ziarcopharma.com

Detailed Description

Update

Ziarco is an independent, clinical stage biotechnology company progressing novel & differentiated therapies for inflammatory and allergic diseases, using both oral and topical routes of delivery. Ziarco has 4 major development programmes staffed by highly experienced drug development professionals.

Current Team (2)

Update

Funding Rounds (2) - $2.9M

Update

Investors (3)

Update
  • 463a2c1156e7d6da58bf79948a584cb1

    TSB Ventures

    We are a private equity investment company that invests financial and intellectual capital in...
  • Cb default image

    Biotechnology Value Fund

    Biotechnology Value Fund, L.P. is an evergreen fund specializing in early stage financing. It...
  • 5d15afe6560240aa115ff4b14ce33d1d

    Pfizer Venture Investments

    Pfizer Venture Investments (PVI) serves as the venture capital arm of Pfizer, supporting a...

Offices/Locations (1)

Update
  • Office

    Lombard House

    12-17 Upper Bridge Street, Offices 205-6, Canterbury

    Kent, CT1 2NF

    GBR